journal article·2024-06-05

Coordination-Driven Self-Assembly of Metal Ion–Antisense Oligonucleotide Nanohybrids for Chronic Bacterial Infection Therapy

Anqi Li, Yan Zhang, Li Wan, Rujue Peng, Xuan Zhang, Qiuyan Guo, Shan Xu, Dan Qiao, Pengwu Zheng, Na Li, Wufu Zhu, Qingshan Pan

ACS Applied Materials & Interfaces· Volume 16· Issue 22
Publisher page

Abstract

Bacterial infection poses a significant challenge to wound healing and skin regeneration, leading to substantial economic burdens on patients and society. Therefore, it is crucial to promptly explore and develop effective methodologies for bacterial infections. Herein, we propose a novel approach for synthesizing nanostructures based on antisense oligonucleotides (ASOs) through the coordination-driven self-assembly of Zn 2+ with ASO molecules. This approach aims to provide effective synergistic therapy for chronic wound infections caused by Staphylococcus aureus ( S. aureus ). The resulting hybrid nanoparticles successfully preserve the structural integrity and biological functionalities of ASOs, demonstrating excellent ASO encapsulation efficiency and bioaccessibility. In vitro antibacterial experiments reveal that Zn-ASO NPs exhibit antimicrobial properties against Escherichia coli, Staphylococcus aureus, and Bacillus subtilis . This antibacterial ability is attributed to the high concentration of metal zinc ions and the generation of high levels of reactive oxygen species. Additionally, the ftsZ-ASO effectively inhibits the expression of the ftsZ gene, further enhancing the antimicrobial effect. In vivo antibacterial assays demonstrate that the Zn-ASO NPs promote optimal skin wound healing and exhibit favorable biocompatibility against S. aureus infections, resulting in a residual infected area of less than 8%. This combined antibacterial strategy, which integrates antisense gene therapy and metal-coordination-directed self-assembly, not only achieves synergistic and augmented antibacterial outcomes but also expands the horizons of ASO coordination chemistry. Moreover, it addresses the gap in the antimicrobial application of metal-coordination ASO self-assembly, thereby advancing the field of ASO-based therapeutic approaches.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, Jiangxi, China

Key Laboratory for Research and Utilization of Characteristic Biological Resources in Southern Yunnan, College of Biological and Agricultural Sciences, Honghe University, Mengzi 661199, China

Funding

Education Department of Jiangxi Province · Science Fund for Distinguished Young Scholars of Jiangxi Province · National Natural Science Foundation of China · Natural Science Foundation of Jiangxi Province · Jiangxi Science and Technology Normal University · Yunnan Province

References (64)

Show source-provided references
1. 10.1001/jama.275.4.30010.1001/jama.275.4.300 ↗
2. 10.7326/0003-4819-137-10-200211190-0000710.7326/0003-4819-137-10-200211190-00007 ↗
3. 10.1038/nrmicro82110.1038/nrmicro821 ↗
4. 10.1038/s41467-021-25120-610.1038/s41467-021-25120-6 ↗
5. 10.1126/science.257.5073.106410.1126/science.257.5073.1064 ↗
6. 10.1016/S1473-3099(17)30753-310.1016/S1473-3099(17)30753-3 ↗
7. Orr R. · Curr. Opin. Mol. Ther. · 2001 · 3 · 288
8. 10.1038/s41573-021-00162-z10.1038/s41573-021-00162-z ↗
9. 10.1016/j.jconrel.2022.10.05010.1016/j.jconrel.2022.10.050 ↗
10. 10.1007/s40820-020-0409-310.1007/s40820-020-0409-3 ↗
11. 10.1021/acsnano.1c0307210.1021/acsnano.1c03072 ↗
12. 10.1021/acsami.1c1558510.1021/acsami.1c15585 ↗
13. 10.1016/j.nantod.2021.10114010.1016/j.nantod.2021.101140 ↗
14. 10.1002/anie.20201117410.1002/anie.202011174 ↗
15. 10.1021/acsami.1c2380810.1021/acsami.1c23808 ↗
16. 10.1002/adma.20230047710.1002/adma.202300477 ↗
17. 10.1016/j.actbio.2023.12.03110.1016/j.actbio.2023.12.031 ↗
18. 10.1126/science.aak997310.1126/science.aak9973 ↗
19. 10.1021/acs.nanolett.5b0049010.1021/acs.nanolett.5b00490 ↗
20. 10.1021/acs.nanolett.8b0216610.1021/acs.nanolett.8b02166 ↗
21. 10.1002/adfm.20230014510.1002/adfm.202300145 ↗
22. 10.1021/jacs.0c0956710.1021/jacs.0c09567 ↗
23. 10.1016/j.actbio.2020.10.02610.1016/j.actbio.2020.10.026 ↗
24. 10.1002/adfm.20200872010.1002/adfm.202008720 ↗
25. 10.1016/j.actbio.2022.12.01210.1016/j.actbio.2022.12.012 ↗
26. 10.1016/j.jcis.2023.11.14310.1016/j.jcis.2023.11.143 ↗
27. 10.1038/nrmicro302810.1038/nrmicro3028 ↗
28. 10.1002/adfm.20191002110.1002/adfm.201910021 ↗
29. 10.1002/9781119951438.eibc0126.pub210.1002/9781119951438.eibc0126.pub2 ↗
30. 10.1007/s10534-010-9406-110.1007/s10534-010-9406-1 ↗
31. 10.3390/ijms1811228510.3390/ijms18112285 ↗
32. 10.1002/adfm.20190938910.1002/adfm.201909389 ↗
33. 10.1021/acsnano.2c0004810.1021/acsnano.2c00048 ↗
34. Cui Y. · Adv. Healthc. Mater. · 2023 · 2302566
35. 10.1021/acsnano.0c0961710.1021/acsnano.0c09617 ↗
36. 10.1016/j.actbio.2023.10.02810.1016/j.actbio.2023.10.028 ↗
37. 10.1021/acsnano.7b0351310.1021/acsnano.7b03513 ↗
38. 10.1002/adfm.20210901110.1002/adfm.202109011 ↗
39. 10.1021/acsnano.0c0400610.1021/acsnano.0c04006 ↗
40. 10.1021/acs.analchem.8b0570610.1021/acs.analchem.8b05706 ↗
41. 10.1002/anie.20191475110.1002/anie.201914751 ↗
42. 10.1002/adfm.20230663410.1002/adfm.202306634 ↗
43. 10.1021/jacs.3c0541310.1021/jacs.3c05413 ↗
44. 10.1002/anie.20200595010.1002/anie.202005950 ↗
45. 10.1002/adfm.20190995410.1002/adfm.201909954 ↗
46. 10.1021/jacs.2c1359710.1021/jacs.2c13597 ↗
47. 10.1021/jacs.9b0391410.1021/jacs.9b03914 ↗
48. 10.1002/anie.20181073510.1002/anie.201810735 ↗
49. 10.1016/j.ccr.2015.02.00710.1016/j.ccr.2015.02.007 ↗
50. 10.1093/nar/gkg23810.1093/nar/gkg238 ↗
51. 10.1039/cs993220025510.1039/cs9932200255 ↗
52. 10.1021/ar900197y10.1021/ar900197y ↗
53. 10.1016/j.ijid.2014.09.01510.1016/j.ijid.2014.09.015 ↗
54. 10.1042/BJ2007089110.1042/BJ20070891 ↗
55. 10.1021/acs.biochem.7b0034610.1021/acs.biochem.7b00346 ↗
56. 10.1038/s41579-021-00638-010.1038/s41579-021-00638-0 ↗
57. 10.1021/acsnano.7b0185010.1021/acsnano.7b01850 ↗
58. 10.1038/s41467-020-19425-110.1038/s41467-020-19425-1 ↗
59. 10.1016/j.bioactmat.2020.07.01310.1016/j.bioactmat.2020.07.013 ↗
60. 10.1002/adhm.20230198410.1002/adhm.202301984 ↗
61. 10.1002/adfm.20221472610.1002/adfm.202214726 ↗
62. 10.1016/j.cej.2023.14434510.1016/j.cej.2023.144345 ↗
63. 10.1016/j.actbio.2023.05.04810.1016/j.actbio.2023.05.048 ↗
64. 10.1016/j.cej.2023.14183710.1016/j.cej.2023.141837 ↗